Healthcare provider recognition of pregnancy related risks and management considerations in patients with tuberous sclerosis complex.

Written By David Ritter

Meredith Rose, David Ritter, Nishant Gupta, Leandra Tolusso, Paul Horn, Emily Wakefield & Jennifer Glass

Orphanet J Rare Dis 19, 4 (2024). https://doi.org/10.1186/s13023-023-03015-7

Provider survey showing that providers view pregnancy with TSC as higher risk than normal. However, there is a wide variety of opinions about what should be done and how to manage mTOR inhibitors during the pregnancy. We suggest the development of consensus statements from experts in the field to help guide pregnancy care.

https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-03015-7

David Ritter
Previous

Exploring the neurological features of individuals with germline PTEN variants: A multicenter study
Next

Estradiol- and Progesterone-Associated Changes in microRNA-Induced Silencing and Reduced Antiseizure Efficacy of an Antagomir in Female Mice